Publications
Showing 451 to 460 of 561 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada | Laforce, R., Rosa-Neto, P., Soucy, J. P., Rabinovici, G. D., Dubois, B., & Gauthier, S. | 2016 | Canadian Journal of Neurological Sciences |
| Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment | Smith EE*, Barber P*, Field TS*, Ganesh A, Hachinski V*, Hogan DB*, Lanctôt KL*, Lindsay MP, Sharma M*, Schwartz RH, Ismail Z*, Gauthier S*, Black SE* | 2020 | Alzheimer's & Dementia |
| CAN-THUMBS UP | Nygaard HB*, Chertkow H*, Feldman HH*, Belleville S*, Montero-Odasso M* | 2021 | Alzheimer's & Dementia |
| Can we help care providers communicate more effectively with persons having dementia living in long-term care homes? | McGilton, K. S., Rochon, E., Sidani, S., Shaw, A., Ben-David, B. M., Saragosa, M., Boscart, V. M., Wilson, R., Galimidi-Epstein, K. K., & Pichora-Fuller, M. K. | 2017 | American Journal of Alzheimer's Disease and other Dementias |
| C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism. | Zhang, M.**, Xi, Z., Misquitta, K., Sato, C., Moreno, D., Liang, Y., Slow, E., Rogaeva, E., & Tartaglia, M. C. | 2017 | Movement Disorders |
| C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism. | Zhang M, Xi Z, Misquitta K, Sato C, Moreno D, Liang Y, Slow E, Rogaeva E, Tartaglia MC | Movement Disorders | |
| Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories | Heal, M.**, McFall, G. P.*, Vergote, D., Jhamandas, J. H.*, Westaway, D.*, & Dixon, R. A.* | 2022 | Journal of Alzheimer's Disease |
| Body mass index predicts cognitive aging trajectories selectively for females: Evidence from the Victoria Longitudinal | Bohn L, McFall GP, Wiebe SA, Dixon RA* | 2020 | Neuropsychology |
| Blood-based biomarkers of agitation in Alzheimer’s disease: Advances and future prospects | Tumati, S.**, Herrmann, N.*, Marotta, G.*, Li, A., & Lanctôt, K. L.* | 2021 | Neurochemistry international |
| Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts | Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Scholl M, Massarweh G, Soucy JP, Hoglund K, Brinkmalm G, Mattsson N, Palmqvist S, Gauthier S*, Stomrud E, Zetterberg H, Hansson O, Rosa-Neto P*, Blennow K. | 2020 | Lancet Neurology |
Showing 451 to 460 of 561 Publications